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PRESIDENTIAL ADDRESS 
PSYCHOENDOCRINOLOGY AND BEHAVIOUR 
G. C. BORAL • 
Words are inadequate to express my 
deep sense of gratitude to you for electing 
me to the prestigious office of the President 
of the Indian Psychiatric Society. In the 
same breath I express a haunting sense of 
awareness of the stupendous responsibility 
associated with this high office. Indeed, 
you have put a "giant's robe" on a dwarfs 
shoulders. But "apparel oft proclaims the 
man". I assure you, I shall endeavour to rise 
to.the occassion and play to the best of my 
ability the role you have assigned to me. I 
swear to protect, preserve and defend the 
image, interest and dignity of the society. In 
the discharge of my duties as the President 
of the Indian Psychiatric Society, I will do 
everything humbly possible to promote all 
that the Society stands for. The aims and 
objectives of our Society, as I sec them, are 
inseparably interwoven with the past, pres-
ent and future of Psychiatry in India. This 
holistic view of our profession and associa-
tion inspires to embark upon a task that will 
demand the last ounce of my energy. 
The Indian Psychiatric Society was born 
in the year India won freedom. The tre-
mendous upsurge of activity generated in 
all spheres of life in the wake of freedom 
created a social, cultural and scientific clim-
ate that motivated the founding fathers of 
our society to establish a professional orga-
nisation befitting a free nation. In the late 
forties and fifties they built it up almost 
from a scratch. But they worked with great 
fortitude and vision. There was a time 
when psychiatry - in all aspects of the pro-
fession (practice, teaching and research) -
was a weakling surviving in isolation be-
hind the high walls of the mental hospitals. 
Today it has grown up to be a strong and 
younger number of the scientific commu-
nity both professionally and academically. 
A profession bom of the biosocial sciences 
cannot maintain its spurt of growth 
without the fresh blood of new knowledge. 
During the last quarter of a century our 
members have contributed significantly to 
the pool of new knowledge in Psychiatry. It 
is heartening to note that the members of 
the younger generation have taken up re-
search work with enthusiasm and have 
shown power and promise. This orientation 
to research is a sign of vitality and augurs 
well for our profession. Thanks to this aca-
demic tilt in our attitude, we have been able 
to keep abreast of the recent advances made 
at International level in our speciality - at 
least in ideas, if not in facilities for render-
ing relict. 
The dichotomy between "pure" and 
"applied" in modern science is hardly ten-
able today. What was considered "pure" 
yesterday will find its "applied" significance 
tomorrow. This is true for many areas of 
psychobiological research. Psychoendocri-
nology is one such area. From a pure labora-
tory science, it has spread its sway over us 
from the classroom to the clinic. I feel, the 
time is ripe for a careful consideration of 
the nature, content and relevance of Psy-
choendocrinology to Psychiatry. 
Psychotndocrinology is a field of Psy-
chobiology which studies the inter rela-
tionship between the endocrine system and 
behaviour, that is - the influence of hor-
mones on behaviour and the effect of beha-
viour and psychological stimuli on the 
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functioning of the endocrine system. Among 
the principal aims of psychoendocrinology 
arc (a) the identification and measurement of 
manifestation and parameters of the recipro-
cal endocrine - behaviour influence, (b) the 
elucidation of the neuro-endocrine mecha-
nisms involved in this influence and (c) un- * 
demanding of the implications of endocrine-
behaviour relationship for adaptive behaviour 
as well as for physical and mental health. 
Though psychoendocrinology has come 
of its own as a special branch of psychobiokv 
gy during our lifetime, its foundations were 
laid many, many years ago. Those who are 
un lined to we thing* from historical perspec-
tives, may trace the origin of this science in 
the humoral theory prevalent in the days of 
Hipprocrates and Galen or the concept of • 
Tridosha" propounded by the Indian sages 
of Ayurveda which precedes Charaka and 
Susruta. Even those who are not prepared to 
delve so deep into the archives of history 
must concede that the seeds were sowed in 
the clinical observations and studies made in 
the early nineteenth century. In 1825 C. H. 
Parry referred to the emotional and beha-
vioural changes in exophthalamic goitre. Ma-
ny physiologists and psychiatrists have corro-
borated him and noted behavioural changes, 
at times severe psychopathology, in patients 
with endocrine disorders or in those with ac-
cidental or surgical destruction of ductless 
glands. In 1849 the German scientist A. A. 
Bert hold did some animal experiments and 
came to the conclusion that testicular secre-
tions were responsible for their sexual beha-
viour and some other behavioural characte-
ristics. In later years experimentations were 
extruded to humans. The first known experi-
ment was performed by C. E. Hrown Se-
Hiiord, the famous French Physician and one 
<>! the founders of endocrinology. In 1889 he 
mircicd himself with animal testicular ex-
11 >. t. A man in his seventies, he reported that 
lie got back his youthful vigour, appearance 
and sexual appetite. Whatever be the fallacy 
of his experiment, it led to a tremendous 
boost in clinical medicine (Wolmen 1975). It 
needs to be made clear that these observers 
and experimenters were not aware of the na-
ture of the chemical secreted by these duct-
less glands. In 1902 Bayliss and Starling got an 
inkling of the nature of the secretion of these 
glands and in 1905 Sterling named it "Hor-
mone" (the Greek word Hormein means "I 
arouse" or "I excite"). 
During the early years of the present cen-
tury much research, and publication centred 
round the possibility of endocrine involve-
ment in some mental disorders. These re-
search activities encouraged the use of hor-
mones in the treatment of mental disorders. 
Among the works on endocrinological psy-
chiatry of historical prominence were the 
studies of M. Laignel-Lavestine of France 
(1908). Serious experimentations with hu-
mans, however, began around 1920. The 
well-known experiments by G. Maranon of 
Spain (1887-1960) may be considered the be-
ginning of experimental psychoendocrinolo-
gy of man. He conducted experiment on the 
effect of adrenaline injection on emotions 
and on other reactions in man. These experi-
ments received wide attention and prompted 
extensive work in this area throughout Eu-
rope and America. Taking the cues from the 
works of W. B. Cannon on the effects of 
emotion on the sympathetic nervous system, 
Hans Seh/e, in 1936, investigated on the acti-
vation of the Pituitary adrenal cortical system 
in stress. His studies profoundly influenced 
psychoendocrinological research as they di-
rected attention to the sensitivity and respon-
siveness of hormonal secretion to psychologi-
cal stimulation. Inspired by Seh/e's concept of 
stress, some pioneering workers in India took 
up the studies in this area in the midriroes. 
Nandi and Banerjee (1958) reported on adre-
nocortical runctkns in some mental Jiseascs 
bv metnods which were considered upeodacc-
at the tune but finer methods, e.g. radioim-
munoassay were still unavailable to them. It 
is, however, noteworthy that their findings G. C. BORAL  5 
were mostly corroborated by later studies 
us ing the radioimmunoassay. 
This area of research was the initial 
springboard of the work of Max Reiss (1900-
1970). Early in his scientific career Reiss 
could recognise the intimate link between 
the brain and the endocrine system and per-
ceived, as implication for psychiatry. Since 
1939 he had been concentrating his whole at-
tention on the role of endocrines on mental 
health. It is he who applied the name psy-
choendocrinology to this area of research. Reiss 
was instrumental in organising the Psychoen-
docrine association which held its first sym-
posium in Zurich in 1957 and in the follow-
ing year, the first book bearing the title Psy-
choendocrinology was published under his 
editorship. In 1969 an international organisa-
tion, with Max Reiss as its first President, was 
formed in Milan, Italy, under the name Inter-
national Society ot Psychoendocrinology. Its 
membership indicates the wide spectrum of 
specialities with which Psychoendocrinology 
is associated as a field of research. Workers in 
the area ot endocrinology, psychiatry, psy-
chology, biochemistry, pharmacology and 
neurophysiology are actively involved in the 
activities of this society. In the same year a 
journal named "Hormones and Behaviour" 
was also launched. Modem research, as it re-
veals with increasing precision the interaction 
between die nervous and endocrine systems, 
prowies soentrSc base and framework for 
the eipJccjoon and interpretation of the en-
docrine-behaviour rebtionship. Moreover, 
the improved methods of measurement of 
hormones in body fluids and tissues as well as 
the identification and synthesis of several key 
harmones particularly the hypothalamic re-
leasing factors, have greatly aided and broa-
dened psychoendocrine research. 
The scope of psychoendocrine research 
is wide and ever expanding. Among the 
topics vigourously pursued at present are: 
(a) the effects of various forms of stress on 
the endocrine system (b) interaction bet-
ween hormones, neurotransmitters and 
psychoactive drugs (c) Hormonal factors in 
sexual behaviour, emotions, aggressive be-
haviour, learning and memory functions (d) 
hormonal correlates of mental illness and 
the use of hormones in the treatment of 
mental and behavioural disorders (e) hor-
monal regulation of homeostatic mechan-
ism and biological drives. 
New insights on behaviour endocrine 
functions are being derived from studies on 
the early influences on ontogenesis of beha-
viour and brain development and on the ef-
fects of early experience on endocrine 
functions in adult life (Wolmen 1975). 
To understand the properties and func-
tions of hormones we must take note of its 
long evolutionary history from earliest liv-
ing matter to the Homo-sapicns. It is gene-
rally conceded that the factors involved in 
the first appearance of the various hor-
mones is largely a matter of conjecture. It 
is, however, known that hormones are one 
of the mechanisms for chemical regulations 
which are found in living things at all stages 
of development. Perhaps chemical regula-
tors including hormones appeared first as 
metabolic by-products. Many important 
features of the vertebrate endocrine system 
were present in the primitive jawlcss verte-
brates and these features were presumably 
present in their fossil ancestors that lived 
more than five million years ago. The evo-
lution of the endocrine system in the more 
advanced vertebrates has involved both the 
appearance of new hormones and the fur-
ther evolution of some of those already 
present in their primitive ancestors. 
That hormones are one of the principal 
co-determinants of behaviour have been 
brought home by the classical experiments 
done on nonhuman primates about two de-
cades ago. It was shown that parental hor-
mones play a crucial role not only in the 
anatomical differentiation of the species 
but also in the modulation of the behaviour ISYUIOfiNDOCRlNOLOGY AND BEHAVIOUR  6 
specific for its male or female members 
(Ehrhardt 1975). 
If androgen is present at a critical time 
of differentiation, the exposed animal will 
exhibit more male-like behaviour when sti-
mulated with androgen in adulthood. If 
androgen is not present, the probability in-
creases that female behaviour will occur af-
ter exposure to female sex hormones of the 
genetic sex i.e. it can be produced experi-
mentally, contrary to the animal's genetic 
sex. The clinical replica of this condition is 
the Adrenogenital syndrome (AGS) - a 
condition in which the adrenal glands have 
a genetically determined defect in their 
function from foetal life on. The genetic 
defect prevents the adrenal cortex from 
synthesizing Cortisol but releases too much 
of a male sex hormone which is androgenic 
in biological action. The most prominent 
results of prenatal androgens on behaviour 
in genetic females as studied by Ehrhardt 
and Haker on a group of 27 patients cluster 
round three things: activity and aggression, 
marriage and materialism, and gender role. 
In all these sphercs.of behaviour and adjust-
ment they were significantly different from 
the control females. It has long been gene-
rally believed by psychiatrists and other cli-
nicians that stress plavs a role in the rrw-
,*t>t ot the physiology and pathology o! 
stress (1950) has nude this belief more po-
pular and widespread in the scientific fra-
ternity. Psychosocial stress, properly speak-
ing stress as a consequence of psychosocial 
stimuli, has been the subject of modem re-
search in psychoendocrinology. Many in-
novations and precisions brought about by 
.vorkrrs in this area have added much to 
our knowledge of the relationship between 
.tress and psychopathology. In the past ex-
perimental designs relied on situational cri-
•cria of emotional states with the assump-
ion that all subjects would experience si-
nilar emotional arousal in a given stressful 
situation. It soon became apparent that this 
was not a safe assumption in view of the 
wide range of individual differences in 
their response to the same stressful situa-
tion. Methodological refinements have 
brought quantitative and objective esti-
mates of emotional states of subjects under 
study. They have cleared up some of the 
puzzles of previous research findings and 
have extended the studies beyond signs of 
emotionality to include an evaluation of the 
style and effectiveness or psychological def-
ence mechanisms. Present knowledge of 
the excellent assay methods or hormones 
has made it possible to apply psychoendo-
crine approaches to the experimental study 
of a range of issues in psychiatric theory -
e.g. the study of neurotic, psychotic and 
psychosomatic processes including the role 
of developmental and social factors in such 
processes. 
Some of the most intriguing leads 
emerging from this approach include the 
possibility that hormone levels may reflect 
certain neurotic processes. A number of ob-
servations have been reported that suggest 
that marked psychologically induced hor-
monal changes can occur in certain subjects 
in the absence oi overt signs or even subjec-
tive awareness of rrmvvwa' FTOOIKWI It 
x«uoitN UK £v<t*ibi;iCN ;hai ciiev may pro-
vide psychophysiological support for the 
concept of neurotic repression of affect or 
at least reflect unconscious processes would 
seem to deserve careful consideration (Ma-
son 1975). Time is not far when the 
stream of psychoendocrine research will 
augment the stream of psychoanalytic re-
search and will enrich the field of psychia-
try. The pioneering work of Knapp and his 
associates in refining methodological ap-
proaches for the collection and utilization 
of psychoanalytical data in psychosomatic 
research has already provided some useful 
guidelines for further work along these 
lines (Ibid). Recent reports from clinical G. C. BQRAL  7 
fields have elaborated this concept. Henry 
and Stephen (1977) are of the opinion that 
psychosocial stress may be involved in the 
pathogenesis of several psychosomatic di-
sorders. In idiopathic hirsutism, a condition 
which is often accompanied by severe men-
tal agony, hyperactivity of the endocrine 
system seems to be of pathogenic signific-
ance as shown by the elevation of the level 
of adrenal androgens above a critical value 
for the induction of hair growth of the mas-
culine type. Incidentally, the stress concept 
has been discussed not only in relation to 
the disorder itself, but also with respect to 
the mechanism of action of one of the most 
effective therepies namely ECT. Such 
treatment acts, indeed, as a stressor on the 
endocrine system, the Hypothalamo-Pitui-
tary-Adrenal System in particular. This me-
chanism is, however, of no apparent thera-
peutic significance in depression. It is now 
clear that psychoendocrinology provides us 
with an experimental approach with which 
we may evaluate at a new level of insight, 
the possibility that a number of illnesses 
may represent not local or regional diseases 
but disorders of the integrative machinery 
according to the time-honoured clinical 
formulations of psychosomatic medicine. 
While the relationships between stressful 
life situations and onset of illness have 
long been recognized, psych oendocrine 
approaches now provide us with new le-
verage in getting at the bodily mecha-
nisms that play a mediating role between 
the psychosocial input and diseased tissue. 
Now let us focus our attention to the rela-
tionship between the endocrine system 
and certain clinical conditions. Though 
this relationship has not yet been clarified 
and many blind spots in our knowledge 
sriU remain, the known facts are sufficient 
to elucidate some of the mysteries of 
mental disorders. The nature of the ill-
ness, their diagnosis and the mode of ac-
tion of some of the remedial measures 
(psychoactive drugs) have all been en-
compassed and enlightened by research fin-
dings in this area. 
In a relatively high percentage (more 
than 10-20%) of patients with either hypo 
or hyperadrenocorticism severe mental dis-
turbances occur episodically or, more sel-
dom, persistently. Confusional states (pre-
dominantly in Addisonian crisis), paranoid 
delusions and affective disorders - com-
monly of a depressed type-can be observed. 
In spite of the overall similarity between 
the hypo and hyperfunction of the adrenal 
gland, the frequency distribution of the va-
rious psychopathological syndromes do 
show some remarkable differences. De-
pression is more common in Cushing's 
syndrome than in Addison's disease (Why-
brow and Hurwitz 1976). It is not surpris-
ing that similar mental abnormalities may 
appear as a consequence of long term thera-
py with high dose of Cortisol and most 
other glucocorticoids used for therapeutic 
purposes. There is, however, ground to 
conclude that an optimum level of gluco-
corticoids is a requirement for normal 
mood and mentation. Marked deviations 
from this hormonal optimum tend to be as-
sociated with mental abnormalities predo-
minantly in the emotional sphere, with de-
pression of a varying degree as the most 
prominent feature. This leads us to the ex-
ploration of other endocrine abnormalities 
in depression which may clarify some of 
the neurochemical abnormalities of aetio-
logical and diagnostic significance. 
The relationship between endocrine 
function and depressive illness has been stu-
died extensively and a plethora of data can 
•ow be adduced to establish its importance 
in the understanding of the pathophysiolo-
gy of this illness. But the crux of the prob-
lem is that many of these findings require 
additional study before definitive conclu-
sions can be based on them. 
It has, however, gained wide acceptance 
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in depression. There is flattening ot the 
diurnal rhythm and elevation of the Cortisol 
levels particularly at those times when Cor-
tisol is normally the lowest. There is also an 
increase in the secretory episodes. An al-
tered 24 hour rhythm of serum prolactin 
has also been reported. The thyroid stimu-
lating hormone (TSI I) response to the thy-
roid releasing hormone (TRM) is reduced 
in a significant percentage of depressed pa-
tients. 
There are several reports (which re-
quire replication studies) about reduced lu-
teinizing hormone (LH) response to 
Luteinizing hormone-releasing hormone 
(LHRH) in postmenopausal depressed wo-
men and hyperrcsponsiveness of the LH re-
sponse to LHRH in some secondary de-
pressed men. 
It has been postulated that a central neu-
rotransmitter defect is at the heart of the 
depressive syndrome. The deficit is be-
lieved to involve different types of ncuro-
iiansitiitieis. II thru* air in fuel dilierent 
111 ittf-1 lying abnormalities in depression, 
they should he reflected in the different cli-
nical symptom complexes. It is of some in-
terest, therefore, that there is increasing 
evidence that primary depressive illness 
differs from secondary depressive illness in 
a number of areas. It appears that hypercor-
ti<oh\m. abnormal dexamcthasonc sup-
pn-<.M,Mi rrspiMivv. tnliiiv ol the TNH re-
. ... ,,. "K-),' ,., ' s. I...v.. v v,v.l. kN 
- , V. v •. . . » -. l.svv >> svV 
,*.v.l »1\ ->\ 1^\ \\l,\k\ 
Melatonin shows a marked diurnal 
ilivibni. One ot the core characteristics of 
depressive illness is also an alteration in di-
minal rhythm. Hence melatonin has been 
<Mudied by workers enthusiastically. Hut the 
|. iirn-nt view is that the existence of an al-
tered rhythm of Cortisol in depressed pa-
tients does not necessarily imply that there 
is in alteration of melatonin. Recent studies 
have shown that the factors controlling me-
latonin and adrenal rhythm differ. 
The technique that appears to be the 
most promising in the investigation of neu-
rotransmitter theory ot depression is a phar-
macoendocrine strategy. In this method, 
agents which specifically alter neurotrans-
mitter function are employed to study the 
endocrine changes. An example of this ap-
proach is the recent investigation in which 
the effect of lithium on endocrine function 
has been examined. It has been suggested 
that lithium acts to limit changes in recep-
tors, particularly by preventing the super 
sensivity of dopamine receptors. These ide-
ary are derived from animal experiments. 
The best results are expected from studies 
on human controls and depressed patients. 
The progress of research lies in this direc-
tion (Brown et al 1981). 
It has been found that rapid intravenous 
administration of TRH to otherwise un-
treated unipolar depressed female patients 
caused a rapid though bnet and partial im-
provement m depressive symptoms (Prange 
et al 1975). Some workers have found simi-
lar response in the bipolar form of the disor-
der also. The frequent though not invari-
able, improvement in depressive symptoms 
produced by TRH may not be its most valu-
able contribution to the understanding of 
depressive disorders. There i> broad aprre-
nvnt fh.»i if. A-tv.-**.*, '>i.'»;-n.- -»?.:'.?;-• 
<y\.••;*;_ v_o.c\.x Vi.x .'-i
1^ :v i;
,:^c*v:cr'j 
to uv.cx»>-o IU^-K-.SC rtwruci on :i>? pi-
tuitary gland trom elevated thyroid hor-
mone. In one oli our studies (Horal et al 
1980) we found that there was deficiency 
of both T3 and T4 in a sample of depres-
sives comprising both males and females. 
The deficiency was more marked in the fe-
male cases. 
These findings mav lead us to believe 
that in depression hypothalami,.- TRH ac-G. CBORAL  9 
gvity is diminished and this in turn leads to 
a paucity of releasable TSH. In depression 
there is also a deficiency of the growth hor- • 
mone response to insulin induced hypogly-
cemia. Somatotropin Release Inhibiting 
Factor (SRIF), of course, inhibits the release 
of growth hormone. Recently it has also 
Keen shown to inhibit TRH induced release 
of TSH: it is reasonable to suggest, there-
fore, that in depression there is increased 
activity of SRIF. This suggestion is consis-
tent with what is known, about the beha-
vioural effect of this substance on experi-
mental animals. Further light may be .. 
thrown on this issue by the study of SRIF 
injected animal as a pharmacological model 
of depression. 
As a footnote to this discussion of the re-
lationship between depressive state and hy-
pothalamo pituitary thyroid dysfunction, I 
would like to emphasise its clinical signific-
ance. In continuation of what I have said 
about the experimental use of TRH in de-
pression, it may be added that Takahashi et 
al (1975) made clinical trial of TRH with 
unipramine in severe relapsing cases of de-
pression. Though TRH had no advantage 
over imipramine there was no doubt that it 
as more effective than placebo. Those who 
are enthusiastic about its use as a therapeut-
ic agent, believe that studies of the mechan-
ism of action of TRH and of its endogenous 
metabolism will identify a sub-group of de-
pressives in which its use will be more ap-
propriate. The use of thyroxine in some 
cases of refractory depressive is now too 
common to bear repetition. 
The knowledge of the Hypothalamo-
Htuitary-Adrenocortical System (HAPS) 
dysfunction in depression has found its cli-
nical utility in the development of a labora-
tory procedure to positively identify the 
type of depression in the inpatient and even 
in outpatient setting. I am alluding to the 
Dexamethasone Suppression Test (DST). 
The test has already become so well-known 
that I take the liberty to skip the description 
of the test procedure. The mechanism of 
action of DST has not yet been fully eluci-
dated. It is, however, known that under 
normal condition Corticotropin Releasing 
Factor (CRF) of the hypothalamus in-
creases the secretion of Cortisol. The nega-
tive feed back of high level of Cortisol on 
the CRF is supposed to act through norad-
renergic neurons which inhibit the CRF 
and the rest of the chain reaction occur. In 
depression noradrenergic neuronal activity 
is diminished. As a result, its inhibiting ac-
tion on CRF is also dininished and CRF se-
cretion becomes uninhibited which leads 
to increased ACTH and Cortisol. When 
Dexamethasone is injected into a depressed 
patient, it fails to suppress the CRF-ACTH 
axis as the noradrenergic neurons no longer 
perform their usual duty of inhibiting the 
CRF. Carroll et al (1980) have extensively 
worked on the DST for the evaluation of 
depression. Abnormal test results were 
found in about half of the patients with cli-
nical diagnosis of endogeneous depression, 
compared to 2 % of the patients with non-
endogenous depression. The predictive va-
lue of an abnormal test result for the diag-
nosis of endogenous depression was 95%. 
The test can be performed easily in an out-
patient setting and requires only a single 
blood sample. The high specificity and the 
simplicity of the test make it useful as part 
of the routine diagnostic evaluation of de-
pressed patients. 
The attention of the Psychiatrists has re-
cently been drawn to Prolactin, a hormone 
secreted by the Pituitary, under control of 
the hypothalamus, for its tremendous po-
tential as as index of hypothalamic activity 
during psychiatric illness. It has already 
found its use is the study of mechanism of 
action of psychoactive drugs. It is known 
that all the antipsychotic drugs currently in 
use increase prolactin level. This effect is 
believed to be a consequence of their dopa-10  PSYCHOENDOCRINOLOGY AND BEHAVIOUR 
mine-bloclcing properties which are direct-
ly proportional to their clinical potency. In 
clinical psychiatry this knowledge can be 
used to detect drug compliance in psychot-
ic patients, since normal levels of prolactin 
would imply either that the patient is not 
taking his antipsychotic drugs or that they 
are not getting into the blood. Since Prolac-
tin may be an indicator of central dopami-
nergic activity, it has been used to unders-
tand the chemical pathology in a variety of 
clinical disorders where central monoam-
ine abnormalities have been suspected. In 
schizophrenics, the basal prolactin is nor-
mal (Meltzcr and Fang 1976). Rotrosen et 
al (1976) gave prolactin suppression test to 
17 patients who fulfilled the Feighner's cri-
teria for schizophrenia and reported hypo-
sensitivity to apomorphine compared with 
the control group. Tamminger et al (1977) 
had also reported hyposensitive prolactin 
responses in chronic schizophrenic patients 
following suppression with both apomor-
phine and L-dopa. The difference in the 
prolactin responses between the schizoph-
renic patients and the controls were inter-
preted as indicating a central abnormality 
of dopaminergic activity. Studies on prolac-
tin response in depression, Parkinson's des-
ease and Huntington's Chorea show that 
hypothalamic dopamine mechanisms may 
be present in those disorders. Prolactin 
changes in grand mal seizures are quite in-
teresting. Timble et al, (1980) have report-
ed that measuring prolactin 20 minutes af-
ter a grand mal seizure may establish the 
diagnosis of epilepsy where it is in doubt, 
especially where hysteria is suspected. If 
this report is replicated and easy method of 
estimation is made available, it will certain-
ly be a useful tool in the hands of the clini-
cians. 
Concluding Remarks 
The latest developments in psychoen-
docrine research have opened up possibili-
ties that substances called neuropeptides 
act in the central nervous system and in the 
hypothalamus to modulate the release of 
hypothalamic releasing or inhibiting hor-
mones. Bolus (1980) made observations 
which indicate that peptides like endor-
phins and enkephalins interact with the 
CNS in a multiple way and thereby serve 
behavioural adaptation. Additionally, 
subtle derangements in physiological me-
chanisms regulating ^-endorphin ho-
moeostasis may be the actiological basis of 
certain mental disorders. 
It has been postulated that accumula-
tion of/^-Endorphin might explain the cata-
tonic form of schizophrenic psychosis. Ani-
mal experimentation with er-type endor-
phins and human study with amphetamine 
toxicity give rise to the possibility that an 
excess of a-type endorphins may be respon-
sible for the paranoid form of schizophrenis 
(Wied, 1978). The pathogenesis of schi-
zophrenic psychosis is supposed to be 
based on the disorder of endorphin bal-
ance. If this supposition is established by 
further studies, schizophrenic psychosis 
may be considered as neuroendocrine dis-
ease and treated like other hormonal di-
sorders. 
It has now become evident that the 
brain is a major endocrine organ both as a 
source of neurally active peptides and as a 
target of peptides of pituitary origin. Neu-
ropeptides or fragments of these molecules 
affect learning, memory, motivational, al-
tentionaL sexual and sleep processes. In 
short, they serve as transmitters of more or 
less specific brain processes. The biologic 
substrate of these processes is the limbic 
system. 
This is a major departure from the tradi-
tional view of physiologists and may be a 
prelude to yet another revolution in psy-
chiatry. We should not be content to be 
mere witness to this revolution. Let us par-
ticipate in that revolution. G. C. BORAL  It 
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